Ross C. Gruber
Sanofi (United States)(US)Takeda (United States)(US)
Publications by Year
Research Areas
Protein Tyrosine Phosphatases, Immune Cell Function and Interaction, Chronic Lymphocytic Leukemia Research, Cytokine Signaling Pathways and Interactions, Phagocytosis and Immune Regulation
Most-Cited Works
- → Induction of IL-33 expression and activity in central nervous system glia(2008)209 cited
- → RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis(2021)134 cited
- → Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients(2011)105 cited
- → The role of TAM family receptors and ligands in the nervous system: From development to pathobiology(2018)92 cited
- → Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype(2009)83 cited
- → Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis(2014)80 cited
- → Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure(2017)78 cited
- → SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients(2008)61 cited
- → Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy(2018)53 cited
- → Modulation of Macrophage Infiltration and Inflammatory Activity by the Phosphatase SHP-1 in Virus-Induced Demyelinating Disease(2008)49 cited